Literature DB >> 24574538

Antibodies to the HMW1/HMW2 and Hia adhesins of nontypeable haemophilus influenzae mediate broad-based opsonophagocytic killing of homologous and heterologous strains.

Linda E Winter1, Stephen J Barenkamp.   

Abstract

The HMW1/HMW2 and Hia proteins are highly immunogenic surface adhesins of nontypeable Haemophilus influenzae (NTHi). Approximately 75% of NTHi strains express HMW1/HMW2 adhesins, and most of the remaining 25% express an Hia adhesin. Our objective in this study was to assess the ability of antisera raised against purified HMW1/HMW2 proteins or recombinant Hia proteins to mediate opsonophagocytic killing of a large panel of unrelated NTHi strains. Native HMW1/HMW2 proteins were purified from three HMW1/HMW2-expressing NTHi strains. Recombinant fusion proteins expressing surface-exposed segments of either of two prototype Hia proteins were purified from Escherichia coli transformants. Immune sera raised in guinea pigs were assessed for their ability to mediate killing of NTHi in an opsonophagocytic assay with the HL-60 phagocytic cell line. The three HMW1/HMW2 antisera mediated killing of 22 of 65, 43 of 65, and 28 of 65 unrelated HMW1/HMW2-expressing NTHi strains, respectively. As a group, the three sera mediated killing of 48 of 65 HMW1/HMW2-expressing strains. The two Hia immune sera mediated killing of 12 of 24 and 13 of 24 unrelated Hia-expressing NTHi strains, respectively. Together, they mediated killing of 15 of 24 Hia-expressing strains. Neither the HMW1/HMW2 nor the Hia antisera mediated killing of NTHi expressing the alternative adhesin type. Antibodies directed against native HMW1/HMW2 proteins and recombinant Hia proteins are capable of mediating broad-based opsonophagocytic killing of homologous and heterologous NTHi strains. A vaccine formulated with a limited number of HMW1/HMW2 and Hia proteins might provide protection against disease caused by most NTHi strains.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24574538      PMCID: PMC4018882          DOI: 10.1128/CVI.00772-13

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  65 in total

Review 1.  Trimeric autotransporters: a distinct subfamily of autotransporter proteins.

Authors:  Shane E Cotter; Neeraj K Surana; Joseph W St Geme
Journal:  Trends Microbiol       Date:  2005-05       Impact factor: 17.079

Review 2.  Use of HL-60 cell line to measure opsonic capacity of pneumococcal antibodies.

Authors:  R A Fleck; S Romero-Steiner; M H Nahm
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

3.  Trimeric autotransporter adhesins: variable structure, common function.

Authors:  Dirk Linke; Tanja Riess; Ingo B Autenrieth; Andrei Lupas; Volkhard A J Kempf
Journal:  Trends Microbiol       Date:  2006-05-05       Impact factor: 17.079

Review 4.  Vaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges.

Authors:  Timothy F Murphy
Journal:  Expert Rev Vaccines       Date:  2005-12       Impact factor: 5.217

5.  Variation in expression of the Haemophilus influenzae HMW adhesins: a prokaryotic system reminiscent of eukaryotes.

Authors:  S Dawid; S J Barenkamp; J W St Geme
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

6.  Adaptation of Haemophilus influenzae to acquired and innate humoral immunity based on phase variation of lipopolysaccharide.

Authors:  J N Weiser; N Pan
Journal:  Mol Microbiol       Date:  1998-11       Impact factor: 3.501

7.  Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection.

Authors:  L O Bakaletz; B J Kennedy; L A Novotny; G Duquesne; J Cohen; Y Lobet
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

8.  Investigation of non-typeable Haemophilus influenzae outer membrane protein P6 as a new carrier for lipooligosaccharide conjugate vaccines.

Authors:  Tinghuai Wu; Jing Chen; Timothy F Murphy; Bruce A Green; Xin-Xing Gu
Journal:  Vaccine       Date:  2005-10-25       Impact factor: 3.641

9.  Antibodies directed at a conserved motif in loop 6 of outer membrane protein P2 of nontypeable Haemophilus influenzae recognize multiple strains in immunoassays.

Authors:  John M Neary; Timothy F Murphy
Journal:  FEMS Immunol Med Microbiol       Date:  2006-03

10.  Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study.

Authors:  Roman Prymula; Pascal Peeters; Viktor Chrobok; Pavla Kriz; Elena Novakova; Eva Kaliskova; Igor Kohl; Patricia Lommel; Jan Poolman; Jean-Paul Prieels; Lode Schuerman
Journal:  Lancet       Date:  2006-03-04       Impact factor: 79.321

View more
  12 in total

1.  Selection and Counterselection of Hia Expression Reveals a Key Role for Phase-Variable Expression of Hia in Infection Caused by Nontypeable Haemophilus influenzae.

Authors:  John M Atack; Linda E Winter; Joseph A Jurcisek; Lauren O Bakaletz; Stephen J Barenkamp; Michael P Jennings
Journal:  J Infect Dis       Date:  2015-02-23       Impact factor: 5.226

Review 2.  Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.

Authors:  Christian P Ahearn; Mary C Gallo; Timothy F Murphy
Journal:  Pathog Dis       Date:  2017-06-01       Impact factor: 3.166

3.  Naturally Acquired HMW1- and HMW2-Specific Serum Antibodies in Adults and Children Mediate Opsonophagocytic Killing of Nontypeable Haemophilus influenzae.

Authors:  Linda E Winter; Stephen J Barenkamp
Journal:  Clin Vaccine Immunol       Date:  2015-10-28

4.  Biofilm biology and vaccine strategies for otitis media due to nontypeable Haemophilus influenzae.

Authors:  Laura A Novotny; Kenneth L Brockman; Elaine M Mokrzan; Joseph A Jurcisek; Lauren O Bakaletz
Journal:  J Pediatr Infect Dis       Date:  2018-07-06       Impact factor: 0.293

5.  Prevalence, distribution, and sequence diversity of hmwA among commensal and otitis media non-typeable Haemophilus influenzae.

Authors:  Gregg S Davis; May Patel; James Hammond; Lixin Zhang; Suzanne Dawid; Carl F Marrs; Janet R Gilsdorf
Journal:  Infect Genet Evol       Date:  2014-10-05       Impact factor: 3.342

Review 6.  Panel 6: Vaccines.

Authors:  Melinda M Pettigrew; Mark R Alderson; Lauren O Bakaletz; Stephen J Barenkamp; Anders P Hakansson; Kevin M Mason; Johanna Nokso-Koivisto; Janak Patel; Stephen I Pelton; Timothy F Murphy
Journal:  Otolaryngol Head Neck Surg       Date:  2017-04       Impact factor: 3.497

7.  Immunogenicity of Nontypeable Haemophilus influenzae Outer Membrane Vesicles and Protective Ability in the Chinchilla Model of Otitis Media.

Authors:  Linda E Winter; Stephen J Barenkamp
Journal:  Clin Vaccine Immunol       Date:  2017-10-05

Review 8.  Vaccine Candidates against Nontypeable Haemophilus influenzae: a Review

Authors:  Ava Behrouzi; Fatemeh Rahimi-Jamnani; Seyed Davar Siadat
Journal:  Iran Biomed J       Date:  2017-03-01

9.  Nontypeable Haemophilus influenzae Has Evolved Preferential Use of N-Acetylneuraminic Acid as a Host Adaptation.

Authors:  Preston S K Ng; Christopher J Day; John M Atack; Lauren E Hartley-Tassell; Linda E Winter; Tal Marshanski; Vered Padler-Karavani; Ajit Varki; Stephen J Barenkamp; Michael A Apicella; Michael P Jennings
Journal:  mBio       Date:  2019-05-07       Impact factor: 7.867

10.  A biphasic epigenetic switch controls immunoevasion, virulence and niche adaptation in non-typeable Haemophilus influenzae.

Authors:  John M Atack; Yogitha N Srikhanta; Kate L Fox; Joseph A Jurcisek; Kenneth L Brockman; Tyson A Clark; Matthew Boitano; Peter M Power; Freda E-C Jen; Alastair G McEwan; Sean M Grimmond; Arnold L Smith; Stephen J Barenkamp; Jonas Korlach; Lauren O Bakaletz; Michael P Jennings
Journal:  Nat Commun       Date:  2015-07-28       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.